Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This study aims at investigating if adjunctive buprenorphine at low dose to treatment as
usual is effective in reducing severe suicidal ideas in major depressive episode, and at
determining the most effective dose.